Selection of optimal therapeutic modality for early-stage extranodal natural killer/T-cell lymphoma patients under the guidance of single-nucleotide polymorphism signature

Detalles Bibliográficos
Autores principales: Yang, Dong-Hua, Chen, Zhe-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977089/
https://www.ncbi.nlm.nih.gov/pubmed/34431759
http://dx.doi.org/10.17305/bjbms.2021.6419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977089/
https://www.ncbi.nlm.nih.gov/pubmed/34431759
http://dx.doi.org/10.17305/bjbms.2021.6419

Ejemplares similares